ID-Cap System Uses Advanced Wireless Technology to Reliably Track Ingestion Events GAINESVILLE, Fla. (December 9, 2019) – etectRx®, Inc. (etectRx), a privately-held digital health company, today announced U.S. Food and Drug Administration (FDA)...
Read moreFormative Qualitative Response of MSM with Substance Use to Digital Pills for PrEP Adherence
Presented by Dr. Peter Chai at IAPAC. Posted on June 14, 2019
1476
0
Technology You Ingest: Interview with Harry Travis
Harry Travis, president & CEO of etectRx, interviewed with the Orlando Entrepreneurs podcast to share the company story. Listen here at https://www.orlandoentrepreneurs.org/technology-you-ingest-interview-with-harry-travis/
Read moreetectRx, Inc. Announces Issuance of Additional U.S. Patents for Ingestible Medication Adherence System
GAINESVILLE, Fla. (June 10, 2019) – etectRx™ Inc., an early-stage digital health company, today announced that the United States Patent and Trademark Office has issued U.S. Patent 10,292,642 for an “Electronic Medication Compliance...
Read moreBioequivalence of Tenofovir Component of Tenofovir/Rilpivirine/Emtricitabine in Digital Pills
Presented by Dr. Peter Chai at IAPAC. Posted on June 6, 2019
1332
0
etectRx and Qualicaps Extend Strategic Relationship to Develop ID-Cap Technologies and Digital Pharma Market Opportunities
Qualicaps® to Display ID-Capsule™ Technology at INTERPHEX Week Japan GAINESVILLE, Fla. (June 6, 2019) – etectRx™ and Qualicaps® have extended their existing collaborative relationship to further develop the manufacturing and...
Read moreetectRx’s Innovative ID-Cap System Selected to Track Medication Ingestion in HIV Prevention Study
Digital Medicine System has the potential to provide clinicians with a new tool to track and manage adherence for HIV prevention therapy GAINESVILLE, Fla. (March 4, 2019) – etectRx™, a privately held digital health company, is pleased to...
Read moreDigital Pills May Be on the Horizon in Cancer Care
CEO of etectRx, Harry Travis, spoke with Oncology Live about digital pills, like the ID-Capsule, as a possibility for improving cancer care. Read more...
Read moreGuardian angel or watchdog? Pills of capecitabine contain sensors
CEO of etectRx, Harry Travis, spoke with MDedge about the future of digital medicine and how our state-of-the-art ID-Cap system can impact the medical industry. Read more...
Read moreetectRx Officially Moves into the University of Florida’s Innovation Hub
etectRx on February 26, 2018
3108
0
We are proud to announce that etectRx has officially moved into the UF Innovation Hub’s ultra-modern facilities, providing our team the additional lab and office space needed to keep our work progressing in new and exciting directions. At...
Read moreUF’s Newly Expanded Innovation Hub Welcomes etectRx
etectRx™ is committed to advancing digital health through extensive research and innovation. When considering a location for the new office, it was crucial that the facility not only meet basic needs but also support and promote the...
Read moreetectRx, Inc. Announces Issuance of U.S. Patent for Ingestible Medication Compliance System
GAINESVILLE, Fla. (Sept. 7, 2017) – etectRx™, Inc., an early stage digital health company, today announces that the United States Patent and Trademark Office has issued U.S. Patent 9,743,880 for an “Electronic Medication Compliance Monitoring...
Read more
